AnaptysBio (ANAB) Stock Research

Over a week ago

AnaptysBio falls -10.8%

ANAB

Jul 15, 10:00 AM

AnaptysBio assumed with a Buy at H.C. Wainwright

ANAB

Jun 10, 6:10 AM

AnaptysBio price target raised by $5 at Leerink, here's why

May 15, 10:51 AM

AnaptysBio price target raised by $16 at UBS

ANAB

May 13, 7:33 AM

AnaptysBio price target raised by $12 at Barclays, here's why

ANAB

May 13, 4:56 AM

AnaptysBio reports Q1 EPS ($1.84), consensus (75c)

ANAB

May 12, 4:46 PM

AnaptysBio appoints Christopher Murphy as CFO

ANAB

May 11, 9:32 AM

AnaptysBio price target lowered by $2 at Piper Sandler, here's why

May 4, 7:45 AM

AnaptysBio price target raised by $19 at Leerink

ANAB

Apr 28, 6:21 AM

GSK's TESARO provides update on AnaptysBio litigation

Apr 27, 6:37 AM

Delaware court dismisses Tesaro breach of contract claim against AnaptysBio

Apr 24, 3:45 PM

First Tracks Biotherapeutics initiated with bullish view at Leerink, here's why

Apr 24, 7:31 AM

AnaptysBio price target lowered by $30 at UBS

ANAB

Apr 22, 8:25 AM

AnaptysBio price target lowered by $16 at Barclays, here's why

ANAB

Apr 22, 5:32 AM

AnaptysBio price target lowered to $60 from $90 at UBS

Apr 21, 8:28 AM

AnaptysBio completes separation of First Tracks Biotherapeutics

ANAB

Apr 20, 9:36 AM

AnaptysBio price target raised by $28 at Piper Sandler, here's why

ANAB

Mar 31, 6:43 AM

AnaptysBio announces $100M share repurchase program

ANAB

Mar 27, 9:05 AM

AnaptysBio board approves spin-off of First Tracks Biotherapeutics

ANAB

Mar 27, 9:03 AM

AnaptysBio price target raised by $20 at UBS, here's why

ANAB

Mar 17, 6:44 AM

AnaptysBio price target raised by $14 at Truist, here's why

Mar 9, 7:16 AM

AnaptysBio price target raised by $29 at Stifel, here's why

Mar 5, 6:43 AM

AnaptysBio price target raised by $15 at H.C. Wainwright, here's why

ANAB

Mar 4, 6:08 AM

AnaptysBio price target raised by $1 at Barclays, here's why

ANAB

Mar 4, 5:18 AM

AnaptysBio reports Q4 EPS $1.58, consensus 93c

ANAB

Mar 3, 4:32 PM